{"id":48904,"date":"2022-09-28T12:02:15","date_gmt":"2022-09-28T10:02:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/"},"modified":"2022-09-28T12:02:15","modified_gmt":"2022-09-28T10:02:15","slug":"kurin-inc-announces-successful-fda-audit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/","title":{"rendered":"Kurin, Inc. Announces Successful FDA Audit"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae<\/sup> blood culture collection sets, announced the results of their recent FDA inspection.\n<\/p>\n

<\/a><\/p>\n

\n\u201cI am pleased to announce Kurin has successfully passed an FDA inspection of our manufacturing procedures, records, and facilities,\u201d said Bob Rogers, CEO and Inventor of Kurin. \u201cIn a recent unscheduled visit by the FDA, there were no observations of what are called a 483 non-conformance. We take pride in operating our company under Good Manufacturing Practices (GMP) and a robust Quality System. I am proud of our team for continuing to demonstrate our commitment to excellence and in consistently meeting federal requirements and our elevated expectations for quality.\u201d\n<\/p>\n

\nKurin\u2019s revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, potentially exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening infections caused by C. diff<\/i>.\n<\/p>\n

\nAbout Kurin, Inc.<\/strong>\n<\/p>\n

\nKurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMatt Heindel
\n
Kurin, Inc.
\n
858-752-9514
\n
mattheindel@kurin.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae blood culture collection sets, announced the results of their recent FDA inspection. \u201cI am pleased to announce Kurin has successfully passed an FDA inspection of our manufacturing procedures, records, and facilities,\u201d said Bob Rogers, CEO and Inventor of Kurin. \u201cIn a recent unscheduled visit … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48904","6":"format-standard","7":"category-industry"},"yoast_head":"\nKurin, Inc. Announces Successful FDA Audit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kurin, Inc. Announces Successful FDA Audit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae blood culture collection sets, announced the results of their recent FDA inspection. \u201cI am pleased to announce Kurin has successfully passed an FDA inspection of our manufacturing procedures, records, and facilities,\u201d said Bob Rogers, CEO and Inventor of Kurin. \u201cIn a recent unscheduled visit ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-28T10:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220928005107\/en\/1584296\/21\/KurinLOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Kurin, Inc. Announces Successful FDA Audit\",\"datePublished\":\"2022-09-28T10:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/\"},\"wordCount\":259,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005107\\\/en\\\/1584296\\\/21\\\/KurinLOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/\",\"name\":\"Kurin, Inc. Announces Successful FDA Audit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005107\\\/en\\\/1584296\\\/21\\\/KurinLOGO.jpg\",\"datePublished\":\"2022-09-28T10:02:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005107\\\/en\\\/1584296\\\/21\\\/KurinLOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220928005107\\\/en\\\/1584296\\\/21\\\/KurinLOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/kurin-inc-announces-successful-fda-audit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kurin, Inc. Announces Successful FDA Audit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kurin, Inc. Announces Successful FDA Audit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/","og_locale":"en_US","og_type":"article","og_title":"Kurin, Inc. Announces Successful FDA Audit - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin\u00ae blood culture collection sets, announced the results of their recent FDA inspection. \u201cI am pleased to announce Kurin has successfully passed an FDA inspection of our manufacturing procedures, records, and facilities,\u201d said Bob Rogers, CEO and Inventor of Kurin. \u201cIn a recent unscheduled visit ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-28T10:02:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220928005107\/en\/1584296\/21\/KurinLOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Kurin, Inc. Announces Successful FDA Audit","datePublished":"2022-09-28T10:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/"},"wordCount":259,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220928005107\/en\/1584296\/21\/KurinLOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/","url":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/","name":"Kurin, Inc. Announces Successful FDA Audit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220928005107\/en\/1584296\/21\/KurinLOGO.jpg","datePublished":"2022-09-28T10:02:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220928005107\/en\/1584296\/21\/KurinLOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220928005107\/en\/1584296\/21\/KurinLOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/kurin-inc-announces-successful-fda-audit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Kurin, Inc. Announces Successful FDA Audit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48904"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48904\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}